Cookies show us what works. Privacy
Cookies show us what works. Privacy
28 funds hold it · Insiders trading both ways
Net buying: insiders sold $0 and bought $160K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 29, 2026
Period ending
Sep 30, 2026
Earnings per share
$1.92 expected
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 29, 2026 | $1.84est. $1.92 | -4.04%miss | $2.38BSEC filing | +8.3%from $2.20B |
| Jun 30, 2026Reported Jul 30, 2026 | $1.97est. $1.82 | +8.18%beat | $2.51BSEC filing | +9.9%from $2.29B |
| Mar 31, 2026Reported Apr 30, 2026 | $1.09est. $1.06 | +2.42%beat | $2.18BSEC filing | -4.9%from $2.29B |
| Dec 31, 2025Reported Jan 29, 2026 | $0.75est. $0.72 | +4.15%beat | $1.97BAlpha Vantage | -12.1%from $2.25B |
| Sep 30, 2025Reported Nov 3, 2025 | $1.14est. $1.17 | -2.56%miss | $2.20BSEC filing | -10.6%from $2.46B |
| Jun 30, 2025Reported Jul 31, 2025 | $1.60est. $1.75 | -8.57%miss | $2.29BSEC filing | -3.2%from $2.36B |
| Mar 31, 2025Reported Apr 24, 2025 | $1.91est. $1.89 | +1.06%beat | $2.29BSEC filing | -0.9%from $2.31B |
| Dec 31, 2024Reported Jan 30, 2025 | $1.87est. $1.57 | +19.11%beat | $2.25BAlpha Vantage | +1.8%from $2.21B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.97B | $2.18B | $2.51B | $2.38B |
| Cost of what it sold | $1.64B | $1.75B | $1.95B | $1.85B |
| Gross profit | $338.0M | $431.0M | $560.0M | $532.0M |
| What it spent | ||||
| Research and development | $58.0M | $60.0M | $65.0M | $63.0M |
| Sales and admin | $159.0M | $178.0M | — | $154.0M |
| Other operating costs | — | — | $185.0M | $27.0M |
| Total operating expenses | $217.0M | $238.0M | $250.0M | $244.0M |
| What was left | ||||
| Operating profit | $121.0M | $193.0M | $310.0M | $288.0M |
| Interest on debt | $52.0M | $49.0M | $56.0M | $56.0M |
| Profit before tax | $12.0M | $136.0M | $256.0M | $249.0M |
| Tax | -$93.0M | $29.0M | $72.0M | -$4.0M |
| Net profit | $105.0M | $107.0M | $183.0M | $252.0M |
| EBITDA | $195.0M | $316.0M | $442.0M | $439.0M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Latham & Watkins Advises on Eastman Chemical Company’s US$300 Million Investment-Grade Senior Notes Offering
Leans bullishNov 16Eastman Chemical (EMN) Could Be 13% Undervalued Following Its $300 Million Note Offering
BullishNov 15DEC to inspect Niagara Falls Goodyear plant as full closure nears, date unknown
NeutralNov 13Eastman wins reinstated $375-million DOE award for methanolysis recycling
BullishNov 13La Bola Negra uses Eastman Kodak film produced in Rochester
NeutralNov 13Eastman Chemical Raises $300 Million With 5.500% Notes Due 2030
Leans bullishNov 12Latham & Watkins Advises on Eastman Chemical Company’s US$300 Million Investment-Grade Senior Notes Offering
Leans bullishNov 12Araven adopts BPA-free Tritan Renew for professional food storage containers
BullishNov 12